GILEAD SCIENCES, INC. 4

Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc., sold 3,000 shares of common stock for roughly $390K under a Rule 10b5-1 plan.

On July 15, 2026, Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc., sold 3,000 shares of Gilead common stock under a pre-established Rule 10b5-1 trading plan at an average price of approximately $129.92 per share, for proceeds of about $389,758. Following this planned sale, Mercier’s direct ownership in Gilead common stock stands at 121,234 shares. The sale was executed within a price range of $129.45 to $130.23, as disclosed in the Form 4 footnotes.

Filing Facts

CIK

882095

Ticker

GILD

Form

4

Source Type

fda

Accession

0001782135-26-000026

Alert Tier

7